FIELD: medicine. SUBSTANCE: preparation contains as active substances - isoniaside and pyrasinamide or etambutole hydrochloride, and as additional substances - calcium phosphate dehydrate and/or starch, polyvinylpyrrolidone and/or talc, stearic acid or its salts. The method deals with mixing the active components with calcium phosphate dehydrate and/or starch, moistening the mixture obtained with aqueous solution of starch or polyvinylpyrrolidone followed by granulation, drying and powdering. EFFECT: decreased opportunity of potential tubercular microbacterial resistance to the impact of antibiotics. 5 cl, 3 fig, 3 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
ANTITUBERCULOUS AGENT | 2003 |
|
RU2247559C1 |
COMPOSITE PHARMACEUTICAL COMPOSITION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247561C1 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS DRUG AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2431487C2 |
COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2422145C2 |
Authors
Dates
2002-05-20—Published
2001-02-14—Filed